Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: A comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors

Modern Pathology

Volumn 26, Issue 4, 2013, Pages 502-510

  Robin, Yves Marie ^a   Penel, Nicolas ^a,b   Pérot, Gaëlle ^c   Neuville, Agnes ^c,d   Vélasco, Valérie ^c   Ranchère Vince, Dominique ^e   Terrier, Philippe ^f   Coindre, Jean Michel ^c,d  

^a CENTRE OSCAR LAMBRET   (France)

^b UNIV LILLE   (France)

^c INSTITUT BERGONIÉ   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e CENTRE LÉON BÉRARD   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

immunohistochemistry; smooth muscle differentiation; tissue microarray; transgelin

Indexed keywords

CALDESMON; CALPONIN; DESMIN; H CALDESMON; SMOOTH MUSCLE ACTIN; TRANSGELIN; UNCLASSIFIED DRUG;

ARTICLE; DIAGNOSTIC ACCURACY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MUSCLE DEVELOPMENT; MYXOFIBROSARCOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; SARCOMA; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE; SOFT TISSUE TUMOR; UNDIFFERENTIATED PLEOMORPHIC SARCOMA;

CELL DIFFERENTIATION; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MUSCLE, SMOOTH; PREDICTIVE VALUE OF TESTS; SOFT TISSUE NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876476117     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.192     Document Type: Article

References (27)

1. Mastrangelo G, Coindre JM, Ducimetière F, et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer 2012;118:5339-5348.
2. Fletcher CD, Gustafson P, Rydholm A, et al. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclas-sification. J Clin Oncol 2001;19:3045-3050. (Pubitemid 32565442)
3. Deyrup AT, Haydon RC, Huo D, et al. Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity. Cancer 2003;98:805-813. (Pubitemid 36959278)
4. Cessna MH, Zhou H, Perkins SL, et al. Are myogenin and myoD1 expression specific for rhabdomyosarco-ma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2001;25:1150-1157. (Pubitemid 32777714)
5. Folpe AL, Gown AM. Immunohistochemistry for analysis of soft tissue tumors, In: Weiss SW, Goldblum JR(eds). Enzinger and Weiss's Soft Tissue Tumors, 5th edn. Mosby Elsevier: Maryland Heights, MO, 2008, pp 129-174.
6. Miettinen MM, Sarlomo-Rikala M, Kovatich AJ, et al. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Mod Pathol 1999;12:756-762. (Pubitemid 29383877)
7. Hisaoka M, Wei-Qui s, Jian W, et al. Specific but variable expression of h-caldesmon in leiomyosarco-mas: an immunohistochemical reassessment of a novel myogenic marker. Appl Imm Mol Morph 2001;9:302.
8. Kempson RL, Fletcher CDM, Evans HL, et al. Malignant smooth muscle tumors, In: Kempson RL, Fletcher CDM, Evans HL, Hendrickson MR, Sibley RKAtlas of Tumor Pathology: Tumors of the Soft Tissues. AFIP: Bethesda, MD, USA; 2001, pp. 246-254.
9. Heim-Hall J, Yohe SL. Immunohistochemistry of soft tissue neoplasms. Arch Pathol Lab Med 2008;132: 476-489.
10. Assinder SJ, Stanton JA, Prasad PD. Transgelin: an actin-binding protein and tumor suppressor. Int J Biochem Cell Bio 2009;41:482-486.
11. Perot G, Derré J, Coindre JM, et al. Strong smooth muscle differentiation is dependent on myocardin gene amplification in most human retroperitoneal leiomyosarcomas. Cancer Res 2009;69:2269-2278.
12. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37-42. (Pubitemid 14223231)
13. Evans HL, Shipley J. Leiomyosarcoma, In: Fletcher CD, Krishnan K, Mertens F (eds). WHO Classification of Tumours; Pathology and Genetics: Tumors of Soft Tissue and Bone. IARC Press: Lyon, France; 2002, pp 131-134.
14. Montgomery EA, Meis JM. Nodular fasciitis: its morphologic spectrum and immunohistochemical profile. Am J Surg Pathol 1991;15:942-948.
15. El-Jabbour JN, Bennett MH, Burke MM, et al. Proliferative myositis: an immunohistochemical and ultrastructural study. Am J Surg Pathol 1991;15: 654-659.
16. Lundgren L, Kindblom LG, Willems J, et al. Prolif-erative myositis and fascitis: a light and electron microscopic, cytologic, DNA cytometric and immuno-histochemical study. APMIS 1992;100:437-448.
17. Oda Y, Miyajima K, Kawaguchi K, et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohisto-chemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am J Surg Pathol 2001;25: 1030-1038. (Pubitemid 32685900)
18. Schurch W, Skalli O, Seemayer TA, et al. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin, I: smooth muscle tumors. Am J Pathol 1987;128:91-103. (Pubitemid 17094339)
19. Azumi N, Ben-Ezra J, Battifora H. Immunophenotypic diagnosis of leiomyosarcomas and rhabdomyosarco-mas with monoclonal antibodies to muscle specific actin and desmin in formalin-fixed tissue. Mod Pathol 1988;1:469-474.
20. Swanson PE, Stanley MW, Scheithauer BW, et al. Primary cutaneous leiomyosarcoma: a histologic and immunohistochemical study of 9 cases with ultra-structural correlations. J Cutan Pathol 1988;15: 129-141.
21. Merchant W, Calonje E, Fletcher CD. Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma. Histopathology 1995;27:525-532. (Pubitemid 26022751)
22. Chang A, Schuetze SM, Conrad EU, et al. So-called "inflammatory leiomyosarcoma": a series of 3 cases providing additional insights into a rare entity Int J Surg Pathol 2005;13:185-195. (Pubitemid 40617548)
23. Parham DM, Webber B, Holt H, et al. Immunohisto-chemical study of childhood rhabdomyosarcomas and related neoplasms: results of an intergroup rhabdomyosarcoma study project. Cancer 1991;67: 3072-3080.
24. Schürch W, Bochaton-Piallat ML, Geinoz A, et al. All histological types of primary human rhabdomyosarco-ma express alpha-cardiac and not alpha-skeletal actin messenger RNA. Am J Pathol 1994;144:836-846.
25. Dundr P, Povýsil C, Tvrdik D. Actin expression in neural crest cell-derived tumors including schwanno-mas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors. Pathol Int 2009;59:86-90.
26. Fisher C, Montgomery E, Healy V. Calponin and h-caldesmon expression in synovial sarcoma; the use of calponin in diagnosis. Histopathology 2003;42: 588-593. (Pubitemid 36688153)
27. Pelmus M, Guillou L, Hostein I, et al. Monophasic fibrous and poorly differentiated synovial sarcoma. Immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases. Am J Surg Pathol 2002;26: 1434-1440. (Pubitemid 35239419)